Clinical Trial

Reducing Itch With Hypnosis and Virtual Reality

Study acronym: VRITCH
Recruiting
View on ClinicalTrials.gov →
Summary
Chronic itch is a disabling condition with currently limited treatment options. Virtual reality (VR) is a relatively new approach that provides immersion in another environment and has been shown to have a temporary itch mitigating potential. Hypnosis, which is a state of relaxation, has been successfully applied with more long-term treatment effects in the specific case of itch as a result of severe atopic dermatitis. However, hypnosis tends to depend on an individual's susceptibility, or ease, to come into a hypnotic state. A combination of VR and hypnosis (VRH) has been put forward since it may combine the longer lasting effects of hypnosis with VR making the hypnosis more accessible by facilitating imagination. Even though VRH is a promising avenue, it has never been investigated in the context of itch. In this randomized controlled trial, comparing a VRH treatment with a waiting list control group after 6 sessions and at follow-up, it is aimed to assess the effectiveness of VRH in reducing itch along with its psychological burden in adult individuals with therapy-resistant disabling itch.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-20.
Status change: Not Yet Recruiting → Recruiting 2025-03-24
Trial Details
NCT Number NCT06787794
Lead Sponsor Universiteit Leiden
Collaborators: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions ITCH, Pruritus
Enrollment 30 participants
Start Date 2025-01-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-25